# Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration

> **NCT04021316** · NA · TERMINATED · sponsor: **Imperial College London** · enrollment: 71 (actual)

## Conditions studied

- Venous Ulcer
- Allograft

## Interventions

- **OTHER:** dCELL® Human Dermis (decellularised dermal skin allograft - DCD)
- **OTHER:** Compression bandaging therapy

## Key facts

- **NCT ID:** NCT04021316
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-01
- **Primary completion:** 2023-04-10
- **Final completion:** 2023-04-10
- **Target enrollment:** 71 (ACTUAL)
- **Why stopped:** DMC noted that the primary end point of healed index ulcer at 12 weeks was reached only in 11.5%, whereas a higher figure of 42.5% had been used for the original power calculation, suggesting the trial is significantly underpowered.
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04021316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04021316, "Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04021316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*